Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azomethines agonist compounds of the histamine H.sub.3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation process

Azomethines agonist compounds of the histamine H.sub.3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation process

US Patent 5342960 · Granted Aug 30, 1994

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fatty acid synthase, inhibitors and modifications thereof and its use2025
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Method for the purification of biological macromolecular complexes2022
Proteasome inhibitors2022
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Therapeutical use of H3-ligands2021